Automated Needle Targeting (ANT) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB511244613

Publication Date:

November 15, 2024

Pages:

103

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

ANT analyzes the X-ray or CT images, generates 2D (X-ray) or 3D (CT) models, and the puncture path was automatically calculated and transformed to motion parameters for the puncture robot through the artificial intelligence (AI) algorithms, thereby assisting doctors with accurate biopsies.
The global market for Automated Needle Targeting (ANT) was estimated to be worth US$ 2337.4 million in 2023 and is forecast to a readjusted size of US$ 3407.7 million by 2030 with a CAGR of 5.9% during the forecast period 2024-2030
Increasing demand for minimally invasive procedures: Minimally invasive procedures offer advantages such as shorter hospital stays, faster recovery times, and reduced complications. ANT systems enable healthcare providers to perform these procedures with greater precision, making them more attractive to both patients and healthcare professionals.
Technological advancements: ANT systems continue to benefit from advancements in imaging technologies, such as ultrasound, magnetic resonance imaging (MRI), and computed tomography (CT). These technologies provide real-time, high-resolution imaging, allowing for more accurate needle targeting and placement.
Rising prevalence of chronic diseases: The growing prevalence of chronic diseases like cancer and cardiovascular disorders has led to an increased demand for diagnostic and therapeutic procedures. ANT systems can aid in the precise targeting of tumors, lesions, and other affected areas, improving the effectiveness of treatments.
Improved patient outcomes: The use of ANT systems can reduce the risk of complications associated with needle-based procedures, such as organ damage or bleeding. By improving accuracy and reducing errors, these systems contribute to better patient outcomes and overall satisfaction.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Automated Needle Targeting (ANT), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Automated Needle Targeting (ANT) by region & country, by Type, and by Application.
The Automated Needle Targeting (ANT) market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Automated Needle Targeting (ANT).
Market Segmentation
By Company
NDR Medical
Microport
Zimmer Biomet
Smith & Nephew
Cgbio Inc.
Fraunhofer IPA
Segment by Type:
Percutaneous Lung Biopsy
Percutaneous Nephrolithotomy
Segment by Application
Hospitals
Ambulatory Surgical Center
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Automated Needle Targeting (ANT) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Automated Needle Targeting (ANT) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Automated Needle Targeting (ANT) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Automated Needle Targeting (ANT) Product Introduction
1.2 Global Automated Needle Targeting (ANT) Market Size Forecast
1.2.1 Global Automated Needle Targeting (ANT) Sales Value (2019-2030)
1.2.2 Global Automated Needle Targeting (ANT) Sales Volume (2019-2030)
1.2.3 Global Automated Needle Targeting (ANT) Sales Price (2019-2030)
1.3 Automated Needle Targeting (ANT) Market Trends & Drivers
1.3.1 Automated Needle Targeting (ANT) Industry Trends
1.3.2 Automated Needle Targeting (ANT) Market Drivers & Opportunity
1.3.3 Automated Needle Targeting (ANT) Market Challenges
1.3.4 Automated Needle Targeting (ANT) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Automated Needle Targeting (ANT) Players Revenue Ranking (2023)
2.2 Global Automated Needle Targeting (ANT) Revenue by Company (2019-2024)
2.3 Global Automated Needle Targeting (ANT) Players Sales Volume Ranking (2023)
2.4 Global Automated Needle Targeting (ANT) Sales Volume by Company Players (2019-2024)
2.5 Global Automated Needle Targeting (ANT) Average Price by Company (2019-2024)
2.6 Key Manufacturers Automated Needle Targeting (ANT) Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Automated Needle Targeting (ANT) Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Automated Needle Targeting (ANT)
2.9 Automated Needle Targeting (ANT) Market Competitive Analysis
2.9.1 Automated Needle Targeting (ANT) Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Automated Needle Targeting (ANT) Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Automated Needle Targeting (ANT) as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Percutaneous Lung Biopsy
3.1.2 Percutaneous Nephrolithotomy
3.2 Global Automated Needle Targeting (ANT) Sales Value by Type
3.2.1 Global Automated Needle Targeting (ANT) Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Automated Needle Targeting (ANT) Sales Value, by Type (2019-2030)
3.2.3 Global Automated Needle Targeting (ANT) Sales Value, by Type (%) (2019-2030)
3.3 Global Automated Needle Targeting (ANT) Sales Volume by Type
3.3.1 Global Automated Needle Targeting (ANT) Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Automated Needle Targeting (ANT) Sales Volume, by Type (2019-2030)
3.3.3 Global Automated Needle Targeting (ANT) Sales Volume, by Type (%) (2019-2030)
3.4 Global Automated Needle Targeting (ANT) Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Ambulatory Surgical Center
4.1.3 Others
4.2 Global Automated Needle Targeting (ANT) Sales Value by Application
4.2.1 Global Automated Needle Targeting (ANT) Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Automated Needle Targeting (ANT) Sales Value, by Application (2019-2030)
4.2.3 Global Automated Needle Targeting (ANT) Sales Value, by Application (%) (2019-2030)
4.3 Global Automated Needle Targeting (ANT) Sales Volume by Application
4.3.1 Global Automated Needle Targeting (ANT) Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Automated Needle Targeting (ANT) Sales Volume, by Application (2019-2030)
4.3.3 Global Automated Needle Targeting (ANT) Sales Volume, by Application (%) (2019-2030)
4.4 Global Automated Needle Targeting (ANT) Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Automated Needle Targeting (ANT) Sales Value by Region
5.1.1 Global Automated Needle Targeting (ANT) Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Automated Needle Targeting (ANT) Sales Value by Region (2019-2024)
5.1.3 Global Automated Needle Targeting (ANT) Sales Value by Region (2025-2030)
5.1.4 Global Automated Needle Targeting (ANT) Sales Value by Region (%), (2019-2030)
5.2 Global Automated Needle Targeting (ANT) Sales Volume by Region
5.2.1 Global Automated Needle Targeting (ANT) Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Automated Needle Targeting (ANT) Sales Volume by Region (2019-2024)
5.2.3 Global Automated Needle Targeting (ANT) Sales Volume by Region (2025-2030)
5.2.4 Global Automated Needle Targeting (ANT) Sales Volume by Region (%), (2019-2030)
5.3 Global Automated Needle Targeting (ANT) Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Automated Needle Targeting (ANT) Sales Value, 2019-2030
5.4.2 North America Automated Needle Targeting (ANT) Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Automated Needle Targeting (ANT) Sales Value, 2019-2030
5.5.2 Europe Automated Needle Targeting (ANT) Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Automated Needle Targeting (ANT) Sales Value, 2019-2030
5.6.2 Asia Pacific Automated Needle Targeting (ANT) Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Automated Needle Targeting (ANT) Sales Value, 2019-2030
5.7.2 South America Automated Needle Targeting (ANT) Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Automated Needle Targeting (ANT) Sales Value, 2019-2030
5.8.2 Middle East & Africa Automated Needle Targeting (ANT) Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Automated Needle Targeting (ANT) Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Automated Needle Targeting (ANT) Sales Value
6.2.1 Key Countries/Regions Automated Needle Targeting (ANT) Sales Value, 2019-2030
6.2.2 Key Countries/Regions Automated Needle Targeting (ANT) Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Automated Needle Targeting (ANT) Sales Value, 2019-2030
6.3.2 United States Automated Needle Targeting (ANT) Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Automated Needle Targeting (ANT) Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Automated Needle Targeting (ANT) Sales Value, 2019-2030
6.4.2 Europe Automated Needle Targeting (ANT) Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Automated Needle Targeting (ANT) Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Automated Needle Targeting (ANT) Sales Value, 2019-2030
6.5.2 China Automated Needle Targeting (ANT) Sales Value by Type (%), 2023 VS 2030
6.5.3 China Automated Needle Targeting (ANT) Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Automated Needle Targeting (ANT) Sales Value, 2019-2030
6.6.2 Japan Automated Needle Targeting (ANT) Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Automated Needle Targeting (ANT) Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Automated Needle Targeting (ANT) Sales Value, 2019-2030
6.7.2 South Korea Automated Needle Targeting (ANT) Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Automated Needle Targeting (ANT) Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Automated Needle Targeting (ANT) Sales Value, 2019-2030
6.8.2 Southeast Asia Automated Needle Targeting (ANT) Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Automated Needle Targeting (ANT) Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Automated Needle Targeting (ANT) Sales Value, 2019-2030
6.9.2 India Automated Needle Targeting (ANT) Sales Value by Type (%), 2023 VS 2030
6.9.3 India Automated Needle Targeting (ANT) Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 NDR Medical
7.1.1 NDR Medical Company Information
7.1.2 NDR Medical Introduction and Business Overview
7.1.3 NDR Medical Automated Needle Targeting (ANT) Sales, Revenue and Gross Margin (2019-2024)
7.1.4 NDR Medical Automated Needle Targeting (ANT) Product Offerings
7.1.5 NDR Medical Recent Development
7.2 Microport
7.2.1 Microport Company Information
7.2.2 Microport Introduction and Business Overview
7.2.3 Microport Automated Needle Targeting (ANT) Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Microport Automated Needle Targeting (ANT) Product Offerings
7.2.5 Microport Recent Development
7.3 Zimmer Biomet
7.3.1 Zimmer Biomet Company Information
7.3.2 Zimmer Biomet Introduction and Business Overview
7.3.3 Zimmer Biomet Automated Needle Targeting (ANT) Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Zimmer Biomet Automated Needle Targeting (ANT) Product Offerings
7.3.5 Zimmer Biomet Recent Development
7.4 Smith & Nephew
7.4.1 Smith & Nephew Company Information
7.4.2 Smith & Nephew Introduction and Business Overview
7.4.3 Smith & Nephew Automated Needle Targeting (ANT) Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Smith & Nephew Automated Needle Targeting (ANT) Product Offerings
7.4.5 Smith & Nephew Recent Development
7.5 Cgbio Inc.
7.5.1 Cgbio Inc. Company Information
7.5.2 Cgbio Inc. Introduction and Business Overview
7.5.3 Cgbio Inc. Automated Needle Targeting (ANT) Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Cgbio Inc. Automated Needle Targeting (ANT) Product Offerings
7.5.5 Cgbio Inc. Recent Development
7.6 Fraunhofer IPA
7.6.1 Fraunhofer IPA Company Information
7.6.2 Fraunhofer IPA Introduction and Business Overview
7.6.3 Fraunhofer IPA Automated Needle Targeting (ANT) Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Fraunhofer IPA Automated Needle Targeting (ANT) Product Offerings
7.6.5 Fraunhofer IPA Recent Development
8 Industry Chain Analysis
8.1 Automated Needle Targeting (ANT) Industrial Chain
8.2 Automated Needle Targeting (ANT) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Automated Needle Targeting (ANT) Sales Model
8.5.2 Sales Channel
8.5.3 Automated Needle Targeting (ANT) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

NDR Medical
Microport
Zimmer Biomet
Smith & Nephew
Cgbio Inc.
Fraunhofer IPA

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂